Year: 2024

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public offering (the “Offering”) of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on December 27, 2024 under the ticker symbol “PHH.” The Company expects to receive aggregate gross proceeds of $4.8 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to...

Castellum, Inc. Announces Proposed Public Offering of Common StockCastellum, Inc. (NYSE-American: CTM) (the “Company” or “Castellum”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces that it intends to offer and sell shares of its common stock in a public offering – http://castellumus.com/VIENNA, Va., Dec. 26, 2024 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (the “Company” or “Castellum”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces that it intends to offer and sell shares of its common stock in a public offering. Castellum is offering all of the shares of common stock. The Company initially intends to use the net proceeds of the offering for working capital and general corporate...

Special Meeting of Stockholders To Approve Reverse Stock Split To Be Held on January 14th at 10:00 a.m. ET LOS ANGELES, Dec. 26, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading provider of innovative technology infrastructure solutions that benefit communities and the environment, today provided a letter to shareholders from its CEO and Chairman, Doug Croxall. Dear Fellow Shareholders, As 2024 comes to a close, I want to reflect on Crown’s accomplishments this year and share our vision for the year ahead. It has been a transformative year for Crown, as we have evolved into a rapidly growing public conglomerate with three diversified divisions: Smart Windows, Fiber Optics, and Water Solutions. This year, we made significant operational progress, achieving...

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that its Board of Directors has initiated a process to explore a broad range of strategic alternatives. To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory EBV+ lymphomas (the NAVAL-1 trial). The company emphasized that its decision to voluntarily close the trial is not the result of any new safety finding. “As we continue to look for ways to conserve resources and maximize value for the company, we made the very difficult decision to close the...

New York, NY, Dec. 26, 2024 (GLOBE NEWSWIRE) — NorthView Acquisition Corporation (Nasdaq: NVAC) (the “Company”) announced that it has received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that (i) the Staff has determined that the Company’s securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company’s Common Stock, Rights, and Warrants will be suspended at the opening of business on December 27, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing on The Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the...

WEST PALM BEACH, Fla., Dec. 26, 2024 (GLOBE NEWSWIRE) — Solitron Devices, Inc. (OTC Pink: SODI) (“Solitron” or the “Company”) is pleased to announce fiscal 2025 third quarter bookings were in excess of $8 million.   Bookings in the fiscal 2025 third quarter were approximately $8.0 million as compared to approximately $4.8 million in the fiscal 2024 third quarter. Bookings in the first nine months of fiscal 2025 were approximately $11.8 million as compared to approximately $10.6 million in the first nine months of fiscal 2024.   It should be noted that bookings for the first nine months of fiscal 2024 included only one quarter for MEI, whereas bookings for the first nine months of fiscal 2025 included three quarters for MEI. Backlog as of November 30, 2024, was approximately $12.3 million as compared to approximately $13.0 million...

Reno, Nev., Dec. 26, 2024 (GLOBE NEWSWIRE) —  American Battery Technology Company (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, today announced it has entered into securities purchase agreements with two institutional investors for the purchase and sale of 3,773,586 shares of its common stock and warrants to purchase up to an aggregate of 3,773,586 shares of common stock in a registered direct offering.  The last closing market price was $2.60 per share and this intraday transaction had at a combined offering price of $2.65 per share and accompanying warrant, priced “at-the-market” under Nasdaq rules. The warrants have an exercise price of $2.80 per share, and will be...

MCLEAN, Va., Dec. 26, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today published on its website the National Association of Insurance Commissioners (NAIC) 2024 filing year designations for certain STACR REMIC Trust, STACR Trust, and STACR Debt Notes (collectively, “STACR Notes”). Overall, of the 209 reviewed STACR Notes, all have achieved NAIC 1 Designation including all A1, M1 and M2 Notes offered through 2024 STACR transactions. In addition, 10 of the 2024 NAIC 1 Designations are upgrades from their 2023 NAIC 2 Designations. The below table details the upgrades:CUSIP Deal Name 2023 Year-End NAIC Designation 2023 Year-End NAIC Designation Modifier 2024 Year-End NAIC Designation 2024 Year-End NAIC Designation Modifier35564KB57 STACR 2022-HQA2 M2B 2 B 1 E35564KB65 STACR 2022-HQA2 M2 2 A 1 D35564KE62 STACR 2022-HQA3...